A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients
- 30 November 1997
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 35 (3) , 225-230
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis CEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patientsJournal of Infection, 1995
- Morbidity and mortality from transfusion- transmitted disease in haemophiliaThe Lancet, 1995
- Therapy of Hepatitis CSeminars in Liver Disease, 1995
- The progression of HCV‐associated liver disease in a cohort of haemophilic patientsBritish Journal of Haematology, 1994
- High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in SpainJournal of Infection, 1994
- Treatment with recombinant α‐interferon of chronic hepatitis C in anti‐HIV‐positive patientsJournal of Medical Virology, 1993
- Recombinant Interferon- for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1992
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infectionGastroenterology, 1989